The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification.
Journal Information
Journal Title: Leukemia
Detailed journal information not available.
Publication Details
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare no competing interests."
Funding Disclosure
Evidence found in paper:
"Funding The MDS registry is supported via institutional research support by BMS, Novartis, Abbvie and Jazz Pharmaceuticals. Open Access funding enabled and organized by Projekt DEAL."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025